Cell name:
LN-229
Other names for the model:
LN 229、LN229、LNT-229
Cell information:
LN229 cells are derived from human glioma cells. Click to viewMore information.
Model information:
Subcutaneous inoculation, the mouse strain is NOD/SCID, and matrix needs to be added during inoculation. Approximately 17 days after vaccination, the group can be divided into groups, and the administration time after grouping is approximately 35 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059